Company / Interest Expense per Share
TG Therapeutics, Inc. Interest Expense per Share History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.09
FY2023
5-year range
$0.04 / $0.09
FY2019-FY2023
Trend
+21.1%
vs FY2022
Sector context
#26 of 43
Health Care
What the data says
At $0.09, TG Therapeutics, Inc.'s interest expense per share ranks #18 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2019 to $0.09 in FY2023.
Based on SEC 10-K filings.
0.09 in FY2023 with a 5-year CAGR of +48.4%.
Increased from $0.04 to $0.09 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- +48.4%
- 10-Year CAGR
- -
Sector benchmark
#18 of 43 in Health CareTop 40% of 43This company $0.09 Sector average $18.61
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 21.1% year-over-year.
- Ranks #26 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.09 | +21.1% |
| FY2022 | $0.07 | +77.4% |
| FY2021 | $0.04 | -30.7% |
| FY2020 | $0.06 | +474.3% |
| FY2019 | $0.01 | -16.0% |
| FY2018 | $0.01 | -11.9% |
| FY2017 | $0.01 | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026